|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400082302 |
|
最近更新日期: Date of Last Refreshed on: |
2024-03-26 11:49:19 |
|
注册时间: Date of Registration: |
2024-03-26 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
一项单中心、双盲、随机对照,观察和评估营养联合运动康复方案对胃癌患者围术期肌少症改善效果的临床研究。 |
|
Public title: |
A single-center, double-blind and randomized controlled clinical study to observe and evaluate the effect of nutrition combined with exercise rehabilitation intervention on perioperative sarcopenia in patients with gastric cancer. |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
胃癌合并肌少症患者围手术期营养联合运动康复方案 的构建及实证研究 |
|
Scientific title: |
Construction and empirical study of nutrition combined with exercise rehabilitation program in patients with gastric cancer complicated with sarcopenia during perioperative period |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
蒋小曼 |
研究负责人: |
朱慧娣 |
|
Applicant: |
XIAOMAN JIANG |
Study leader: |
HUIDI ZHU |
|
申请注册联系人电话: Applicant telephone: |
+86 571 8723 7931 |
研究负责人电话:
Study leader's |
+86 571 8723 7931 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1244279760@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1191068@zju.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
浙江省杭州市西湖区梧桐路366号 |
研究负责人通讯地址: |
浙江省杭州市西湖区梧桐路366号 |
|
Applicant address: |
366 Wutong Road, Xihu District, Hangzhou City, Zhejiang Province |
Study leader's address: |
366 Wutong Road, Xihu District, Hangzhou City, Zhejiang Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
浙江大学医学院附属第一医院胃肠外科 |
||
|
Applicant's institution: |
Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhejiang University School of Medicine |
||
|
研究负责人所在单位: |
浙江大学医学院附属第一医院胃肠外科 |
||
|
Affiliation of the Leader: |
Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhejiang University School of Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
浙大一院伦审2022研第059号-会 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
浙江大学医学院附属第一医院临床研究伦理委员会 |
||
|
Name of the ethic committee: |
Clinical Research Ethics Committee of the First Affiliated Hospital of Zhejiang University School of Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-06-27 00:00:00 | ||
|
伦理委员会联系人: |
励有名 |
||
|
Contact Name of the ethic committee: |
YOUMING LI |
||
|
伦理委员会联系地址: |
浙江省杭州市庆春路79号浙江大学医学院附属第一医院 |
||
|
Contact Address of the ethic committee: |
79 qingchun Road, Hangzhou 310003, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 571 8723 3418 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
浙江大学医学院附属第一医院胃肠外科 |
||||||||||||||||||||||
|
Primary sponsor: |
Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhejiang University School of Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省杭州市西湖区梧桐路366号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
366 Wutong Road, Xihu District, Hangzhou City, Zhejiang Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
浙江省卫生健康委员会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Health Commission of Zhejiang Province |
||||||||||||||||||||||
|
研究疾病: |
胃癌合并肌少症 |
||||||||||||||||||||||
|
Target disease: |
Gastric cancer with sarcopenia |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
1构建胃癌肌少症患者围手术期营养联合运动康复方案。 2验证胃癌肌少症患者围手术期营养联合运动康复方案的可行性和有效性。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. To establish a rehabilitation program of nutrition combined with exercise for patients with gastric cancer sarcopenia during perioperative period. 2. To verify the feasibility and effectiveness of perioperative nutrition combined with exercise rehabilitation program for patients with gastric cancer sarcopenia. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①.经病理确诊为胃癌;②.术前1月行腹部CT检查并符合以CT诊断为标准的肌少症;③.接受根治性胃切除术;④.年龄≥18 周岁;⑤.ASA分级为Ⅰ-Ⅲ级;⑥.无幽门梗阻及肠梗阻等不能口服进食情况;⑦.知情同意且自愿参加本研究者。 |
||||||||||||||||||||||
|
Inclusion criteria |
①. Gastric cancer was confirmed by pathology; 2. Abdominal CT examination was performed 1 month before surgery and met the criteria for diagnosing sarcopenia with CT. ③. Undergo radical gastrectomy; ④. Age ≥18 years old; 5.ASA grade is Ⅰ-Ⅲ; 6. no pyloric obstruction and intestinal obstruction can not eat orally; ⑦. Informed consent and voluntary participation in this researcher. |
||||||||||||||||||||||
|
排除标准: |
①.因穿孔、出血等原因行急诊手术者;②.有精神疾病症状及精神疾病病史者;③.合并其他肿瘤者;④.合并影响肢体运动的疾病,如骨折、腰椎间盘突出等;⑤.无法完成6米步速测试或握力测试者;⑥.正在参与其他干预研究者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
①. Emergency operation due to perforation, bleeding and other reasons; (2) People with mental illness symptoms and history of mental illness; ③. Patients with other tumors; (4) Diseases that affect limb movement, such as fractures and lumbar disc herniation; ⑤. Unable to complete the 6-meter pace test or grip strength test; ⑥. Other intervention researchers are being involved. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-04-01 00:00:00至 To 2025-01-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-04-01 00:00:00 至 To 2025-01-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由研究者本人采用数字随机抽样法确定是否纳入研究,单数排除,双数保留,样本收足即可。选取2024年4月至2024年6月符合纳入排除标准的患者,由研究者本人采用数字随机抽样法确定纳入干预组或对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
A numerical random sampling method was adopted by the researcher to determine whether to include in the study, singular numbers were excluded, even numbers were retained, and sufficient samples were collected. Patients meeting the inclusion and exclusion criteria From April to June 2024 were selected to be included in the intervention group or the control group by numerical random sampling by the investigators themselves. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
本研究采用单盲法,受试者不知道自己是在试验组还是对照组,而研究者知道。 |
|
Blinding: |
Single blind method was used in this study, and the subjects did not know whether they were in the test group or the control group, but the investigators did. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
可向研究负责人发送邮件获取原始数据。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Raw data can be obtained by emailing the study leader. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病历记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |